Healthcare reform’s most unlikely winner: India
While the media and Republicans seem obsessed with the problems related to the rollout of healthcare reform, a few entities are rejoicing.
They are about to become very rich or, on some cases, even richer.
The most surprising one of all, however, is not even in America. We analyzed it today in:
Indias pharmaceutical industry eyes vast expansion
India and its generic drug makers are gearing up for a massive expansion as millions of new prescriptions are written for generic drugs covered under the new insurance policies.
This was reported during the height of the government shutdown on Oct. 4 by the BBC in
'Obamacare' boost to Indian pharmaceutical industry
However, before you rush out to buy stock in one of the Indian pharmaceutical companies that stands to benefit, better do some homework.
The industry is rife with problems, and its not difficult to find examples.
It would pay to do a great deal of research on the topic before ingesting prescribed medications imported from India.
And it could cost an arm and a leg if you rush headlong into investing in a drug maker with a dubious track record.